Wilman Luk
Impact in
- Neurology top 2%
- Barrier Structure and Function Studies
- Neuroinflammation and Neurodegeneration Mechanisms
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Alzheimer's disease research and treatments 4
- Co-authors
- Ryan J. WattsYanmei LuKwame HoyteMark S. DennisJasvinder K. AtwalNga Bien‐LySaileta PrabhuJ. Michael Elliott
- Journals
- Science Translational Medicine (3 papers)Neuron (2 papers)The Journal of Experimental Medicine (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Bioanalysis (1 paper)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Wilman Luk
9 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Neurology 457
- Biomaterials 293
- Radiology, Nuclear Medicine and Imaging 470
- Physiology 445
- Molecular Biology 822
Countries citing papers authored by Wilman Luk
This map shows the geographic impact of Wilman Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilman Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilman Luk more than expected).
Fields of papers citing papers by Wilman Luk
This network shows the impact of papers produced by Wilman Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilman Luk. The network helps show where Wilman Luk may publish in the future.
Co-authors
The 25 scholars most cited alongside Wilman Luk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 22 | |
| 2 | 2016 | 6 | |
| 3 | 2015 | 150 | |
| 4 | 2015 | 197 | |
| 5 | 2014 | 244 | |
| 6 | 2014 | 278 | |
| 7 | A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo | 2013 | 45 |
| 8 | Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target Hit paper breakdown → | 2011 | 586 |
| 9 | 2011 | 214 |
About Wilman Luk
Wilman Luk is a scholar working on Radiology, Nuclear Medicine and Imaging, Physiology, Computational Theory and Mathematics, Neurology and Oncology, having authored 9 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Alzheimer's disease research and treatments (4 papers), Glycosylation and Glycoproteins Research (3 papers), Protein purification and stability (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers), Barrier Structure and Function Studies (1 paper) and Cellular transport and secretion (1 paper). The work is most often cited by research in Neurology (457 citations), Biomaterials (293 citations), Radiology, Nuclear Medicine and Imaging (470 citations), Physiology (445 citations) and Molecular Biology (822 citations). Wilman Luk has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Ryan J. Watts, Yanmei Lu, Kwame Hoyte, Mark S. Dennis, Jasvinder K. Atwal, Nga Bien‐Ly, Saileta Prabhu, J. Michael Elliott, Yin Zhang and Margaret Kenrick. Their work appears in journals such as Science Translational Medicine, Neuron, The Journal of Experimental Medicine, CPT Pharmacometrics & Systems Pharmacology and Bioanalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.